Physician profile
Eric W Brown
NPI 1164404737
$3,594.09
in general payments reported to CMS, 2019-2025
26 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $507 · 2021: $666 · 2022: $256 · 2023: $413 · 2024: $471 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,453.67 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $366.61 | 2019-2021 | |
| Allergan, INC. | $281.58 | 2019-2022 | |
| Abbvie INC. | $263.86 | 2022-2025 | Durysta, Alphagan P, Lumigan |
| Ocular Therapeutix, INC. | $128.04 | 2021 | |
| Shire North American Group INC | $127.33 | 2019 | |
| Horizon Therapeutics Plc | $120.00 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $111.79 | 2025 | Xdemvy |
| Sight Sciences, INC. | $111.34 | 2022-2024 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $108.06 | 2022-2025 | Vyzulta, Xipere, Visudyne |
| Integra Lifesciences Corporation | $85.32 | 2019 | |
| Quidel Corporation | $69.17 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $57.58 | 2021 | |
| Coopervision INC. | $53.29 | 2019 | |
| Dompe US, INC. | $38.35 | 2025 | Oxervate |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $25.80 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $25.29 | 2019 | |
| Harrow Eye, LLC | $22.84 | 2025 | Vevye |
| Biotissue Holdings INC. | $21.91 | 2023 | |
| Thea Pharma INC. | $21.77 | 2023 | |
| Rxsight INC | $19.99 | 2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Omeros Corporation | $19.67 | 2020 | |
| Sun Pharmaceutical Industries INC. | $19.20 | 2019 | |
| New World Medical,INC. | $16.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.08 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.